Standard Biotools | FLDM - Ebitda


Standard Biotools reported $-8.01M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Agilent USD 456M 84M Dec/2025
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Bio-Rad Laboratories USD -636.6M 1.62B Mar/2026
Bruker USD 143.2M 33.2M Jun/2026
Danaher USD 1.84B 81M Jun/2026
Illumina USD 330M 80M Jun/2026
Myriad Genetics USD 14.3M 4M Dec/2025
Nikon Corporation JPY 1.83B 9.74B Mar/2026
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Revvity USD 228.18M 44.73M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sony JPY 509.68B 278.36B Mar/2026
Standard Biotools USD -8.01M 7.8M Mar/2026
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Waters USD 712M 545M Jun/2026